Israeli Lab-Grown Meat Producer Wants To Set Up A Plant In Zurich
-
Italiano
it
Carne sintetica: produttore israeliano si insedia nel canton Zurigo
Original
Read more: Carne sintetica: produttore israeliano si insedia nel canton Zurig
The company's goal is to establish the infrastructure required to bring premium-quality meat produced in the laboratory from beef cells to the food market, writes the Zurich Department of Economic Affairs in a statement.
+Get the most important news from Switzerland in your inbox
With this step, the statement says, the company 'completes an important stage in its international expansion and lays the foundation stone for the local production of the cultured meat production line. The agreement also creates a long-term framework for production in the canton of Zurich, from where there is the potential to expand to other European markets.
Aleph Farm was founded in 2017, the following year it presented its first lab-produced steak. In 2021 it expanded to rib-eye steak and then collagen in 2022. The first application to produce synthetic meat in Switzerland was filed in 2023, in collaboration with Migros.
More More Cultured meat: revolution or hype?This content was published on Sep 20, 2022 Lab-grown steak may soon be sold in Switzerland. Will it really be safe and environmentally friendly?
Read more: Cultured meat: revolution or hype
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- VANTIR Launches To Transform Prop Trading With Transparency And Trust
- Brazil Edtech Market Size, Share, Trends, And Forecast 2025-2033
- Next Generation Management Corp. (OTC: NGMC) Announces Strategic Shift Toward Digital Commerce Acquisitions
- PLPC-DBTM: Non-Cellular Oncology Immunotherapy With STIPNAM Traceability, Entering A Global Acquisition Window.
- What Is The Growth Rate Of The Europe Baby Food And Infant Formula Market In 2025?
- Permissionless Data Hub Baselight Taps Walrus To Activate Data Value Onchain
Comments
No comment